日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Extracellular vesicles derived from live or apoptotic mesenchymal stem cells: comparison of the effects of two extracellular vesicles on liver fibrosis

源自活细胞或凋亡间充质干细胞的细胞外囊泡:两种细胞外囊泡对肝纤维化影响的比较

Ju, Ruobing; Tian, Siyuan; Li, Bo; Zhang, Miao; Ma, Shuoyi; Hu, Yinan; Su, Rui; Yang, Fangfang; Xia, Erzhuo; Shang, Yulong; Zhou, Xia; Han, Ying

Host FSTL1 defines the impact of stem cell therapy on liver fibrosis by potentiating the early recruitment of inflammatory macrophages

宿主 FSTL1 通过增强炎症巨噬细胞的早期募集,决定干细胞疗法对肝纤维化的影响。

Zheng, Xiaohong; Tian, Siyuan; Li, Ting; Zhang, Si; Zhou, Xia; Liu, Yansheng; Su, Rui; Zhang, Miao; Li, Bo; Qi, Chao; Guo, Guanya; Ma, Shuoyi; Sun, Keshuai; Yang, Fangfang; Hu, Yinan; Yang, Chunmei; Cui, Lina; Shang, Yulong; Guo, Changcun; Jin, Boquan; Guan, Lei; Wang, Jingbo; Ning, Wen; Han, Ying

The Treatment of Primary Biliary Cholangitis: Time for Personalized Medicine

原发性胆汁性胆管炎的治疗:是时候进行个体化治疗了

Men, Xinyi; Liu, Yansheng; Zhao, Han; Xie, Bingrui; Guo, Changcun; Leung, Patrick S C; Timilsina, Suraj; Gershwin, M Eric; Shang, Yulong; Han, Ying

Engineered Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Mitigate Liver Fibrosis by Delivering USP10 to Reprogram Macrophage Phenotype.

工程化间充质干细胞衍生的小细胞外囊泡通过递送 USP10 重编程巨噬细胞表型来减轻肝纤维化

Tian Siyuan, Zhou Xia, Zheng Linhua, Liu Jingyi, Zhang Miao, Ma Shuoyi, Zheng Xiaohong, Guo Guanya, Ju Ruobing, Yang Fangfang, Liu Yansheng, Li Bo, Hu Yinan, Xia Erzhuo, Su Rui, Sun Keshuai, Cui Lina, Guo Changcun, Zhou Xinmin, Wang Jingbo, Shang Yulong, Han Ying

Definition and validation of recompensation in patients with primary biliary cholangitis-related decompensated cirrhosis treated with ursodeoxycholic acid: Based on the BAVENO VII criteria

基于 BAVENO VII 标准,对接受熊去氧胆酸治疗的原发性胆汁性胆管炎相关失代偿性肝硬化患者的再代偿进行定义和验证

Ding, Dawei; Cui, Lina; Jia, Gui; Wang, Boling; Zheng, Linhua; Deng, Juan; Sun, Ruiqing; Wang, Xiufang; Shang, Yulong; Guo, Guanya; Han, Ying

Off-the-shelf human umbilical cord mesenchymal stromal cell product in acute-on-chronic liver failure: A multicenter phase I/II clinical trial

现成的人脐带间充质干细胞产品治疗急性加慢性肝衰竭:一项多中心 I/II 期临床试验

Cui, Lina; Zou, Huaibin; You, Shaoli; Guo, Changcun; Gu, Jundong; Shang, Yulong; Jia, Gui; Zheng, Linhua; Deng, Juan; Wang, Xiufang; Sun, Ruiqing; Ding, Dawei; Wang, Weijie; Zhou, Xia; Guo, Guanya; Liu, Yansheng; Han, Zhongchao; Han, Zhibo; Chen, Yu; Han, Ying

Low-risk individuals with primary biliary cholangitis and significant liver stiffness: prognosis and treatment

原发性胆汁性胆管炎伴明显肝脏硬度的低风险患者:预后和治疗

Ding, Dawei; Hu, Yinan; Jia, Gui; Wang, Boling; Zheng, Linhua; Deng, Juan; Sun, Ruiqing; Wang, Xiufang; Guo, Guanya; Cui, Lina; Shang, Yulong; Han, Ying

Prognostic model development using novel genetic signature associated with adenosine metabolism and immune status for patients with hepatocellular carcinoma

利用与腺苷代谢和免疫状态相关的新型基因特征构建肝细胞癌患者的预后模型

Chen, Yidan; Wang, Kemei; Zhang, Xingyun; Tao, Dongying; Shang, Yulong; Wang, Ping; Li, Qiang; Liu, Yansheng

Identifying optimal candidates for autologous peripheral blood stem cell therapy in patients with decompensated liver cirrhosis: a prognostic scoring system

识别失代偿期肝硬化患者自体外周血干细胞治疗的最佳候选者:预后评分系统

Tian, Siyuan; Guo, Guanya; Zhou, Xia; Liu, Yansheng; Jia, Gui; Zheng, Linhua; Cui, Lina; Wang, Kemei; Zhang, Miao; Sun, Keshuai; Ma, Shuoyi; Yang, Chunmei; Zhou, Xinmin; Guo, Changcun; Shang, Yulong; Han, Ying

Prognostic significance of liver stiffness in patients with primary biliary cholangitis: validation of Baveno VII criteria

肝脏硬度在原发性胆汁性胆管炎患者中的预后意义:Baveno VII 标准的验证

Ding, Dawei; Guo, Guanya; Cui, Lina; Jia, Gui; Wang, Xiufang; Zhang, Miao; Tian, Siyuan; Zheng, Linhua; Liu, Yansheng; Hu, Yinan; Xuan, Guoyun; Yang, Jiaqi; Yang, Chunmei; Sun, Ruiqing; Deng, Juan; Guo, Changcun; Chen, Yu; Shang, Yulong; Han, Ying